The EU Clinical Trials Regulation (EU CTR) 536/2014 stands as a robust legislative framework designed to streamline and harmonize clinical trial practices throughout the European Union.

Enforced since 2014, its primary objectives are to bolster patient safety, foster transparency, and uphold the highest standards of research integrity within the European clinical trials landscape.

To prepare for the end of the transitional period ending on 31 January 2025 and ensure compliance with the new Regulation, it is essential to understand its main principles.

If you find yourself grappling with what steps to take before the transitional period ends or seek a general understanding of the Regulation, we warmly invite you to join our webinar. Gain insights and clarity on navigating this transition effectively!